文献速递妇科产科

局部晚期宫颈癌手术与影像学淋巴结评估的生存结局比较:倾向性评分匹配分析

Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer: A propensity score-matched analysis.
PubMed 文献 · Gynecol Oncol · 2019-12-14

该回顾性队列分析纳入2000–2017年Mayo Clinic癌症登记库中接受同步放化疗的IB2–IIIB期宫颈鳞癌、腺癌及腺鳞癌患者,经1:2倾向性评分匹配后比较手术与影像学评估盆腔及腹主动脉旁淋巴结的生存结局。手术组35例与影像组70例的5年无进展生存率分别为62.6%与72.4%(HR 1.11,95%CI 0.54–2.30,p=0.77),5年总生存率分别为70.2%与70.5%(HR 1.02,95%CI 0.46–2.29,p=0.96),两组生存结局相当。

要点

  • 手术与影像学评估盆腔及腹主动脉旁淋巴结后接受同步放化疗的局部晚期宫颈癌患者,5年PFS和OS无显著差异。
  • 多因素分析中仅腹主动脉旁淋巴结转移显著预测较差PFS(HR 2.76)和OS(HR 3.46)。
  • 两组局部区域复发和远处转移无差异(p=0.33和0.59)。

核心结论

  • 接受影像学评估盆腔及腹主动脉旁淋巴结的宫颈癌患者,其生存结局与手术评估者相当。

研究设计与样本

  • 回顾性队列分析,纳入2000–2017年Mayo Clinic癌症登记库中完成同步放化疗的IB2–IIIB期宫颈鳞癌、腺癌及腺鳞癌患者148例,行1:2倾向性评分匹配后手术组35例、影像组70例纳入分析。

主要发现

  • 手术组5年PFS为62.6%,影像组为72.4%(HR 1.11,95%CI 0.54–2.30,p=0.77)。
  • 手术组5年OS为70.2%,影像组为70.5%(HR 1.02,95%CI 0.46–2.29,p=0.96)。
  • 单因素分析中FIGO分期、腹主动脉旁淋巴结转移和宫旁受累为PFS和OS的不良预后因素。
  • 多因素分析中仅腹主动脉旁淋巴结转移显著预测较差PFS(HR 2.76,95%CI 1.23–6.18,p=0.01)和OS(HR 3.46,95%CI 1.40–8.55,p=0.01)。
  • 两组局部区域复发(p=0.33)和远处转移(p=0.59)无差异。

临床怎么用

  • 对于局部晚期宫颈癌患者,影像学评估盆腔及腹主动脉旁淋巴结可作为手术评估的替代选择,两者生存结局相当。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate progression-free survival (PFS) and overall survival (OS) between women who underwent surgical versus radiographic assessment of pelvic lymph nodes (PLN) and para-aortic lymph nodes (PALN) prior to chemoradiation therapy for cervical cancer. METHODS: In this retrospective cohort analysis, patients with stage IB2 - IIIB squamous cell, adenocarcinoma and adenosquamous carcinoma of the cervix who completed concurrent chemoradiation therapy (CCRT) between 2000 and 2017 from the Mayo Clinic Cancer Registry were identified. A 1:2 propensity score matching between surgical and imaging groups was performed and PFS and OS were compared between groups. RESULTS: 148 patients were identified and after propensity score matching, 35 from the surgical group and 70 from the imaging group were included in the analysis. There were no statistical differences in baseline characteristics between the 2 groups. The median follow-up time was 41 months (range 7-218) for the surgical group and 51.5 months (range 7-198) for the imaging group. Five-year PFS was 62.6% for the surgical group and 72.4% in imaging group (HR 1.11, 95% CI 0.54-2.30, p = 0.77). Five-year OS was 70.2% for the surgical group and 70.5% for the imaging group (HR 1.02, 95% CI 0.46-2.29, p = 0.96). FIGO stage, PALN metastasis, and parametrial involvement were found to be poor prognosticators for PFS and OS in univariate analysis. Only PALN metastasis significantly predicted unfavorable PFS (HR 2.76, 95% CI 1.23-6.18, p = 0.01) and OS (HR 3.46, 95% CI 1.40-8.55, p = 0.01) in multivariate analysis. There were no differences in locoregional recurrence and distant metastasis between the two groups (p = 0.33 and 0.59 respectively). CONCLUSION: Patients with cervical cancer who underwent radiographic assessment of PLN and PALN had comparable survival outcomes to surgical assessment.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Yang J, Delara R, Magrina J, et al. Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer: A propensity score-matched analysis. Gynecol Oncol. 2019. PMID: 31843274. doi:10.1016/j.ygyno.2019.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。